Cited by 127Angiogenesis and VEGF in CancerLymphatic System and DiseasesAxon Guidance and Neuronal Signaling

Structural basis of Tie2 activation and Tie2/Tie1 heterodimerization

Open access
Leppänen, Veli-Matti, Saharinen, Pipsa, Alitalo, Kari·2017·Proceedings of the National Academy of Sciences

Abstract

Significance: Tie1 and Tie2 receptor tyrosine kinases are key regulators of blood and lymphatic vessel development and of pathological processes including tumor angiogenesis, atherosclerosis, and vascular leakage, e.g., in sepsis. Tie1 is essential for the Tie2 agonist activity of angiopoietins, and the activated receptors form heteromeric complexes in endothelial cell–cell junctions. However, little is known about the activation mechanisms of the Tie receptors. Here we demonstrate that the membrane-proximal domains of Tie2 mediate homotypic interactions, which occur via intermolecular β-sheet formation and are necessary for Tie2 activation. The structural analysis suggests that Tie2/Tie1 heterodimerization occurs by the same mechanism. The crystal structures provide a model for angiopoietin-stimulated Tie2 ectodomain dimerization, clustering, and activation and insights into therapeutic targeting.

Integrity signals

Registry

Crossref · 10.1073/pnas.1616166114

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A model of dimeric ANGPT2147-496 in complex with inactive, half-bent α5β1-integrin and TIE2 ECDs could be created without steric clashes while maintaining the overall geometry and interactions of the existing structures.

    “Interestingly, the model of the dimeric ANGPT2147–496 in complex with the inactive, half-bent α5β1-integrin and TIE2 ECDs could be created without steric clashes while maintaining the overall geometry and interactions of the existing structures found in this study and previously (13, 16, 54–56) (Figure 8, A and B, and Supplemental Video 2).”

The citation lists haven’t been fetched yet

References 57 · Cited by 127

Authors
Leppänen, V.-M., Saharinen, P., & Alitalo, K.
Affiliations
  • Wihuri Research Institute (FI)
  • University of Helsinki (FI)
Venue
Proceedings of the National Academy of Sciences
Published
2017-04-10
Volume
114
Issue
17
Pages
4376-4381
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2606133995
Cited by
127
References
57
Citations by year
2026: 11 · 2025: 11 · 2024: 33 · 2023: 7 · 2022: 16 · 2021: 20 · 2020: 8 · 2019: 12 · 2018: 4 · 2017: 5
FWCI
3.24
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Novo Nordisk Fonden (NNF16OC0023554)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Axon Guidance and Neuronal Signaling
Keywords
Tie2 receptor, receptor heterodimerization, receptor activation, fibronectin type III domain, intermolecular beta-sheet, receptor phosphorylation, congenital glaucoma, receptor clustering, receptor oligomerization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review